The assessment of PCA3 expression directly and specifically in tissue (as opposed to urine) is a novelty and a strength as our primary goal was the study of the PRUNE2/PCA3 regulatory axis in human prostate cancer. The gene discussed is PCA3; the disease is Familial prostate cancer.